Tag: Ledipasvir

CATIE Treatment Update 208

In this issue: HEPATITIS C VIRUS Grazoprevir + elbasvir and other emerging drugs Enter ledipasvir Sirius—ledipasvir + sofosbuvir in cases of severe liver injury Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed Grading severe liver disease and predicting survival Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants Solar-1—ledipasvir +… Read more »

CATIE: HepCinfo Update 5.23

New and Noteworthy Harvoni (ledipasvir + sofosbuvir) approved by Health Canada In October, Health Canada approved the hepatitis C medication Harvoni (ledipasvir + sofosbuvir) for people over the age of 18 with genotype 1 hepatitis C virus. In clinical trials, the cure rate for this combination was 94% to 100%. Ledipasvir and sofosbuvir are both… Read more »